Fertility-preserving treatment in young women with endometrial cancer

Gynakologisch-geburtshilfliche Rundschau

Volumn 46, Issue 1-2, 2006, Pages 25-33

  Böing, Carsten ^a,b   Kimmig, Rainer ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Endometrial adenocarcinoma; Fertility preserving treatment; Hormonal cancer therapy

Indexed keywords

ANASTROZOLE; GESTAGEN; LEUPRORELIN; LEVONORGESTREL; MEGESTROL; PROGESTERONE;

CANCER STAGING; CLINICAL TRIAL; ENDOMETRIUM CARCINOMA; FERTILITY; FOLLOW UP; HUMAN; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; REVIEW; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS, HORMONAL; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFERTILITY, FEMALE; NEOPLASM STAGING; PREGNANCY; PROGESTERONE CONGENERS; SURVIVAL RATE;

EID: 31944433149     PISSN: 10188843     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089974     Document Type: Review

References (91)

1. Cancer Facts and Figures. Atlanta, American Cancer Society, 2005.
2. Schmeler KM, Soliman PT, Sun CC, Slomovitz BM, Gershenson DM, Lu KH: Endometrial cancer in young, normal-weight women. Gynecol Oncol 2005, Epub ahead of print.
3. Crissmann JD, Azoury RS, Barnes AE, Schellhas HF: Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 1981;57:699-704.
4. Dockerty MB, Lovelady SM, Foust GT: Carcinoma of the corpus uteri in young women. Am J Obstet Gynecol 1951;61:966-978.
5. McGee WB: Carcinoma of the endometrium in women under forty years of age. Obstet Gynecol 1958;11:388-390.
6. Kempson RL, Pokorny GE: Adenocarcinoma of the endometrium in women aged forty and younger. Cancer 1968;21:650-662.
7. Peterson EP: Endometrial carcinoma in young women: a clinical profile. Obstet Gynecol 1968;31:702-707.
8. Silverberg SG, Makowski EL, Roche WD: Endometrial carcinoma in women under 40 years of age. Cancer 1977;39:592-598.
9. Jefferey JD, Taylor R, Robertson DI, et al: Endometrial carcinoma occurring in patients under the age of 45 years. Am J Obstet Gynecol 1987;156:366-370.
10. Gallup DG, Stock RJ: Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984;64:417-420.
11. Evans-Metcalf ER, Brooks SE, Reale FR, et al: Profile of women 45 years of age and younger with endometrial cancer. Obstet Gynecol 1998;91:349-354.
12. Tran BN, Connell PP, Waggoner S, Rotmensch J, Mundt AJ: Characteristics and outcome of endometrial carcinoma patients aged 45 years and younger. Am J Clin Oncol 2000;23:476-480.
13. Gitsch G, Hanzal E, Jensen D, et al: Endometrial cancer in premenopausal women 45 years and younger. Obstet Gynecol 1995;85:504-508.
14. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB: Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group Study. Cancer 1987;60:2035-2041.
15. Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, Burke TW, Lu KH: Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol 2005;105:575-580.
16. Obermair A, Geramou M, Gucer F, Denison U, Graf AH, Kapshammer E, Medl M, Rosen A, Wierrani F, Neunteufel W, Frech I, Speiser P, Kainz C, Breitenecker G: Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int J Gynecol Cancer 1999;9:383-386.
17. Lindahl B, Einarsdottir M, Iosif C, Ranstam J, Willen R: Endometrial carcinoma: results of primary surgery on FIGO stages Ia-Ic and predictive value of histopathological parameters. Anticancer Res 1997;17:2297-2302.
18. Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ: Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 1995;86:38-42.
19. Valsecchi L, Mangili G, Frigerio L, Spagnolo DL, De Sanctis L, Ferrari A: Reliability of preoperative evaluation of prognostic factors in endometrial carcinoma. Int J Gynaecol Obstet 1997;59:35-39.
20. Soothill PW, Alcock CJ, MacKenzie IZ: Discrepancy between curettage and hysterectomy histology in patients with stage 1 uterine malignancy. Br J Obstet Gynaecol 1989;96:478-481.
21. Petersen RW, Quinlivan JA, Casper GR, Nicklin JL: Endometrial adenocarcinoma - Presenting pathology is a poor guide to surgical management. Aust NZ J Obstet Gynaecol 2000;40:191-194.
22. Kendall BS, Ronnett BM, Isacson C, Cho KR, Hedrick L, Diener-West M, Kurman RJ: Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 1998;22:1012-1019.
23. Bergeron C, Nogales FF, Masseroli M, Abeler V, Duvillard P, Muller-Holzner E, Pickartz H, Wells M: A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 1999;23:1102-1108.
24. Horn LC, Schnurrbusch U, Bilek K, Hentschel B, Einenkel J: Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatment. Int J Gynecol Cancer 2004;14:348-353.
25. Trimble CL: Atypical endometrial hyperplasia: a tough call. Int J Gynecol Cancer 2005;15:401.
26. Boronow RC, Morrow CP, Creasman WT, et al: Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984;63:825-832.
27. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK: Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996;88:394-398.
28. Randall TC, Kurman RJ: Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997;90:434-440.
29. Kinkel K, Kaji Y, Yu KK, Segal MR, Lu Y, Powell CB, Hricak H: Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999;212:711-718.
30. Sironi S, Colombo E, Villa G, Taccagni G, Belloni C, Garancini P, et al: Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 1992;185:207-212.
31. Yamashita Y, Harada M, Sawada T, Takahashi M, Miyazaki K, Okamura H: Normal uterus and Figo stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology 1993;186:495-501.
32. Hricak H, Stern JL, Fisher MR, Shapeero LG, Winkler ML, Lacey CG: Endometrial carcinoma staging by MR imaging. Radiology 1987;162:297-305.
33. Ito K, Matsumoto T, Nakada T, Nakanishi T, Fujia N, Yamashita H: Assessing myometrial invasion by endometrial carcinoma with dynamic MRI. J Comput Assist Tomogr 1994;18:77-86.
34. Frei KA, Kinkel K, Bonel HM, Lu Y, Zaloudek C, Hricak H: Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging - A meta-analysis and Bayesian analysis. Radiology 2000;216:444-449.
35. Kistner RW: Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium. Cancer 1959;12:1106.
36. Kaku T, Yoshikawa H, Tsuda H, Sakamoto A, Fukunaga M, Kuwabara Y, Hataeg M, Kodama S, Kuzuya K, Sato S, Nishimura T, Hiura M, Nakano H, Iwasaka T, Miyazaki K, Kamura T: Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 2001;167:39-48.
37. Ushijima K, Yoshikawa H, Hirakawa T, Yasugi T, Saito T, Yasuda M, Kuzuya K, Fujii T, Hatae M, Kamura T: Fertility-sparing treatment by high dose oral medroxyprogesterone acetate for endometrial cancer and atypical hyperplasia in young women: a multicentric phase II study (abstract 5022). ASCO Annu Meet, Orlando, 2005.
38. Ferenczy A, Gelfand M: The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol 1989;160:126-131.
39. Rubatt JM, Slomovitz BM, Burke TW, Broaddus RR: Development of metastatic endometrial endometrioid adenocarcinoma while on progestin therapy for endometrial hyperplasia. Gynecol Oncol 2005, Epub ahead of print.
40. Kempson RL, Pokorny GE: Adenocarcinoma of the endometrium in women aged forty and younger. Cancer 1968;21:650-662.
41. O'Neill RT: Pregnancy following hormonal therapy for adenocarcinoma of the endometrium. Am J Obstet Gynecol 1970;108:318-321.
42. Eddy WA: Endometrial carcinoma in Stein-Leventhal syndrome treated with hydroxyprogesterone caproate. Am J Obstet Gynecol 1978;131:581-582.
43. Thornton JG, Brown LA, Wells M, Scott JS: Primary treatment of endometrial cancer with progestagen alone. Lancet 1985;ii:207-208.
44. Paulson RJ, Sauer MV, Lobo RA: Pregnancy after in vitro fertilization in a patient with stage I endometrial carcinoma treated with progestins. Fertil Steril 1990;54:735-736.
45. Lai CH, Hsueh S, Chao AS, Soong YK: Successful pregnancy after tamoxifen and megestrol acetate therapy for endometrial carcinoma. Br J Obstet Gynaecol 1994;101:547-549.
46. Niwa K, Yokoyama Y, Tanaka T, Murase T, Morishita S, Itoh M, Itoh N, Shimokawa K, Tamaya T: Successful pregnancy in a patient with endometrial carcinoma treated with medroxyprogesterone acetate. Arch Gynecol Obstet 1994;255:91-94.
47. Kimmig R, Strowitzki T, Muller-Hocker J, Kurzl R, Korell M, Hepp H: Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol 1995;58:255-257.
48. Zanetta G, Gabriele A, Losa G, Capellini A, Mangioni C: Conservative management of endometrial carcinoma with prolonged preservation of the uterus in a young patient. Int J Gynecol Cancer 1997;7:332-334.
49. Kung FT, Chen WJ, Chou HH, Ko SF, Chang SY: Conservative management of early endometrial adenocarcinoma with repeat curettage and hormone therapy under assistance of hysteroscopy and laparoscopy. Hum Reprod 1997;12:1649-1653.
50. Zuckerman B, Lavie O, Neuman M, Rabinowitz R, Ben Chetrit A, Voss E, et al: Endometrial carcinoma stage I-grade II: conservative treatment followed by a healthy twin pregnancy. Int J Gynecol Cancer 1998;8:172-174.
51. Jobo T, Imai M, Kawaguchi M, Kenmochi M, Kuramoto H: Successful conservative treatment of endometrial carcinoma permitting subsequent pregnancy: report of two cases. Eur J Gynaecol Oncol 2000;21:119-122.
52. Shibahara H, Shigeta M, Toji H, Wakimoto E, Adachi S, Ogasawara T, Takemura T, Koyama K: Successful pregnancy in an infertile patient with conservatively treated endometrial adenocarcinoma after transfer of embryos obtained by intracytoplasmic sperm injection. Hum Reprod 1999;14:1908-1911.
53. Kowalczyk CL, Malone J Jr, Peterson EP, Jacques SM, Leach RE: Well-differentiated endometrial adenocarcinoma in an infertility patient with later conception: a case report. J Reprod Med 1999;44:57-60.
54. Ogawa S, Koike T, Shibahara H, Ohwada M, Suzuki M, Araki S, Sato I: Assisted reproductive technologies in conjunction with conservatively treated endometrial adenocarcinoma: a case report. Gynecol Obstet Invest 2001;51:214-216.
55. Lowe MP, Cooper BC, Sood AK, Davis WA, Syrop CH, Sorosky JI: Implementation of assisted reproductive technologies following conservative management of FIGO grade I endometrial adenocarcinoma and/or complex hyperplasia with atypia. Gynecol Oncol 2003;91:569-572.
56. Nakao Y, Nomiyama M, Kojima K, Matsumoto Y, Yamasaki F, Iwasaka T: Successful pregnancies in 2 infertile patients with endometrial adenocarcinoma. Gynecol Obstet Invest 2004;58:68-71.
57. Yarali H, Bozdag G, Aksu T, Ayhan A: A successful pregnancy after intracytoplasmic sperm injection and embryo transfer in a patient with endometrial cancer who was treated conservatively. Fertil Steril 2004;81:214-216.
58. Mazzon I, Corrado G, Morricone D, Scambia G: Reproductive preservation for treatment of stage IA endometrial cancer in a young woman: hysteroscopic resection. Int J Gynecol Cancer 2005;15:974-978.
59. Kempson RL, Pokorny GE: Adenocarcinoma of the endometrium in women aged forty and younger. Cancer 1968;21:650-662.
60. Farhi DC, Nosanchuk J, Silverberg SG: Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 1986;68:741-745.
61. Lee KR, Scully RE: Complex endometrial hyperplasia and carcinoma in adolescents and young women 15 to 20 years of age: a report of 10 cases. Int J Gynecol Pathol 1989;8:201-213.
62. Sardi J, Anchezar Henry JP, Paniceres G, Gomez Rueda N, Vighi S: Primary hormonal treatment for early endometrial carcinoma. Eur J Gynaecol Oncol 1998;19:565-568.
63. Schammel DP, Mittal KR, Kaplan K, Deligdisch L, Tavassoli FA: Endometrial adenocarcinoma associated with intrauterine pregnancy: a report of five cases and a review of the literature. Int J Gynecol Pathol 1998;17:327-335.
64. Vinker S, Shani A, Open M, Fenig E, Dgani R: Conservative treatment of adenocarcinoma of the endometrium in young patients: is it appropriate? Eur J Obstet Gynecol Reprod Biol 1999;83:63-65.
65. Greenblatt RB, Gambrell RD Jr, Stoddard LD: The protective role of progesterone in the prevention of endometrial cancer. Pathol Res Pract 1982;174:297-318.
66. Salha O, Martin-Hirsch P, Lane G, Sharma V: Endometrial carcinoma in a young patient with polycystic ovarian syndrome: first suspected at time of embryo transfer. Hum Reprod 1997;12:959-962.
67. Muechler EK, Bonfiglio T, Choate J, Huang KE: Pregnancy induced with menotropins in a woman with polycystic ovaries, endometrial hyperplasia, and adenocarcinoma. Fertil Steril 1986;46:973-975.
68. Mitsushita J, Toki T, Kato K, Fujii S, Konishi I: Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate. Gynecol Oncol 2000;79:129-132.
69. Pinto AB, Gopal M, Herzog TJ, Pfeifer JD, Williams DB: Successful in vitro fertilization pregnancy after conservative management of endometrial cancer. Fertil Steril 2001;76:826-829.
70. Huang SY, Jung SM, Ng KK, Chang YC, Lai CH: Ovarian metastasis in a nulliparous woman with endometrial adenocarcinoma failing conservative hormonal treatment. Gynecol Oncol 2005;97:652-655.
71. Kim YB, Holschneider CH, Ghosh K, Nieberg RK, Montz FJ: Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: report of seven cases and review of the literature. Cancer 1997;79:320-327.
72. Randall TC, Kurman RJ: Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 1997;90:434-440.
73. Duska LR, Garrett A, Rueda BR, Haas J, Chang Y, Fuller AF: Endometrial cancer in women 40 years old or younger. Gynecol Oncol 2001;83:388-393.
74. Imai M, Jobo T, Sato R, Kawaguchi M, Kuramoto H: Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus - Usefulness and limitations. Eur J Gynaecol Oncol 2001;22:217-220.
75. Wang CB, Wang CJ, Huang HJ, Hsueh S, Chou HH, Soong YK, Lai CH: Fertility-preserving treatment in young patients with endometrial adenocarcinoma. Cancer 2002; 94: 2192-2198.
76. Gotlieb WH, Beiner ME, Shalmon B, Korach Y, Segal Y, Zmira N, Koupolovic J, Ben-Baruch G: Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 2003;102:718-725.
77. Niwa K, Tagami K, Lian Z, Onogi K, Mori H, Tamaya T: Outcome of fertility-preserving treatment in young women with endometrial carcinomas. Br J Obstet Gynaecol 2005;112:317-320.
78. Montz FJ, Bristow RE, Bovicelli A, Tomacruz R, Kurman RJ: Intrauterine progesterone treatment of early endometrial cancer. Am J Obstet Gynecol 2002;186:651-657.
79. Dhar KK, Needhi Rajan T, Koslowski M, Woolas RP: Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature. Gynecol Oncol 2005;97:924-927.
80. Jones K, Georgiou M, Hyatt D, Spencer T, Thomas H: Endometrial adenocarcinoma following the insertion of Mirena IUCD. Gynecol Oncol 2002;87:216-218.
81. Covens A, Thomas G, Shaw P, Ackerman I, Osborne R, Lukka H, Carey M, Franssen E, Roche K: A phase II study of leuprolide in advanced/recurrent endometrial cancer. Gynecol Oncol 1997;64:126-129.
82. Emons G, Heyl W: Hormonal treatment of endometrial cancer. J Cancer Res Clin Oncol 2000;126:619-623.
83. Asbury RF, Brunetto VL, Lee RB, Reid G, Rocereto TF: Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Am J Clin Oncol 2002;25:557-560.
84. Gallagher CJ, Oliver RT, Ohram DH: A new treatment for endometrial cancer with gonadotropin-releasing hormone analogue. Br J Obstet Gynaecol 1991;98:1037-1041.
85. Jadoul P, Donnez J: Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma. Fertil Steril 2003;80:1315-1324.
86. Ma BB, Oza A, Eisenhauer E, et al: The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers: a study of the National Cancer Institute of Canada Clinical Trials Group. Int J Gynecol Cancer 2004;14:650-658.
87. Murray RML, Pitt P: Treatment of advanced metastatic breast cancer, carcinoma of the prostate and endometrial carcinoma with aminoglutethimide; in Nagel GA, Santen RJ (eds): Aminoglutethimide as an Aromatase Inhibitor in the Treatment of Cancer. Bern, Huber, 1984, pp 109-122.
88. Burnett AF, Bahador A, Amezcua C: Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy. Gynecol Oncol 2004;94:832-834.
89. Thigpen JT, Brandy MF, Alvarez RD, et al: Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 1999;7:1736-1744.
90. Saegusa M, Okayasu I: Progesterone therapy for endometrial carcinoma reduces cell proliferation but does not alter apoptosis. Cancer 1998;83:111-121.
91. Reifenstein EC Jr: The treatment of advanced endometrial cancer with hydroxyprogesterone caproate. Gynecol Oncol 1974;2:377-414.